Airborne ESKAPE Pathogens Show Extensive Antibiotic Resistance in South African Clinic

Researchers from the University of Johannesburg have identified multidrug-resistant ESKAPE bacteria circulating in the air of 1 densely populated inner-city clinic in South Africa. The pathogens, which are notorious for evading standard medical treatments, demonstrated alarming survival rates against both first-line and last-resort antibiotics.[1][2]

The 2026 study, published in the journal Indoor Air, involved sampling the clinic's air to capture suspended bacteria and testing how well they withstood various medications. The results showed that 80.5 percent of the gram-negative bacteria survived exposure to colistin.[1][2]

Colistin is a highly toxic drug reserved exclusively for critical situations when all other treatments have failed, making the high survival rate a significant clinical concern. The discovery highlights a critical vulnerability in healthcare environments where patients gather for routine care.[2]

"These bacteria are very effective in causing infections," said Dr. Lee Heine, the study's lead author and a researcher at the university's Water and Health Research Centre. "They are specifically associated with infections contracted at hospitals and clinics."[1]

Vulnerable Populations at Risk

The ESKAPE group comprises 6 highly virulent pathogens: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species. These bacteria are primary drivers of lower respiratory tract infections, including bronchitis and pneumonia.[2]

In the Johannesburg clinic samples, the researchers detailed specific resistance profiles that complicate standard treatment protocols. Among the gram-negative ESKAPE bacteria tested, a highly concerning resistance to both first-line and last-resort drugs was found.[2]

The airborne presence of these pathogens poses a severe and immediate threat to patients with weakened immune systems. South Africa currently experiences some of the world's highest rates of HIV and tuberculosis co-infection, leaving a large portion of the population highly susceptible to severe respiratory illnesses when visiting medical facilities.[1]

"Using antibiotics to treat infection relies on an intact immune system," Heine explained, noting that the body must work alongside the medication to eliminate the bacteria. "Without an intact immune system, treatment can be prolonged or unsuccessful."[1]

"If patients are already immunocompromised, then the risk of death due to pneumonia caused by a multidrug-resistant strain of one of these bacteria increases, as they are likely to spread to the bloodstream and cause sepsis," Heine noted.[1]

Contamination Reaches Neonatal Wards

The threat of untreatable infections extends beyond outpatient clinics and into the most sensitive hospital environments. In a related 2026 study published in Infection Prevention in Practice, the same research team detected ESKAPE bacteria in 1 public hospital's neonatal intensive care unit (NICU) located in the same city.[2]

Led by Professor Tobias Barnard, director of the Water and Health Research Centre, the team collected hundreds of swabs from incubator surfaces. They also gathered handwash samples from nurses, doctors, clerks, and cleaning staff working in the NICU.[2]

The analysis revealed that more than 85 percent of the ESKAPE bacteria recovered from the neonatal unit were classified as multidrug-resistant. The presence of these pathogens on incubators and staff hands illustrates how easily resistant strains can migrate through a facility.[2]

Newborns in intensive care possess underdeveloped immune systems, making any exposure to multidrug-resistant bacteria a potentially fatal event. The high resistance rates suggest that standard cleaning protocols may be insufficient to eradicate the most hardened strains.[1][2]

Rethinking Infection Control

To combat the spread of these airborne and surface-dwelling superbugs across the 2 related studies, the researchers are urging medical facilities to fundamentally update their safety protocols. Heine proposed that routine monitoring for bacterial and fungal air contamination must become a standard, mandated component of infection control in healthcare settings.[2]

The clinic and NICU in the studies are among many medical facilities worldwide struggling to reduce the number of patients acquiring lower respiratory tract infections during their treatment. The findings underscore a growing global crisis in antimicrobial resistance, where the clinical environment itself acts as a reservoir for superbugs.[1]